When Is Watchful Waiting Safe for Severe Aortic Stenosis?
At a Glance
Watchful waiting can be safe for people with severe aortic stenosis who are truly symptom-free and have stable heart function, but it requires regular echocardiograms and prompt action if symptoms, reduced pumping function, or other high-risk test findings appear.
In this answer
5 sections
If you have severe aortic stenosis but feel completely fine, “active surveillance” (often called watchful waiting) is usually a safe initial approach, provided you undergo close, structured monitoring. However, doctors do not rely on how you feel alone. Your Heart Team—a specialized group of cardiologists, surgeons, and imaging experts—will use objective tests to look for warning signs that your heart is struggling.
Severe aortic stenosis is diagnosed using multiple measurements, including the valve’s area, the mean pressure gradient (the pressure difference across the valve), and the speed of blood flow [1]. If specific warning signs appear on your tests, aortic valve replacement (TAVR or SAVR) is generally recommended to protect your heart before obvious symptoms or permanent damage develop.
Verifying You Are Truly Asymptomatic
It is common for people to unconsciously adapt their lifestyle to avoid symptoms. You might stop taking the stairs or walk a little slower without realizing it. To confirm that your severe aortic stenosis is truly asymptomatic, your doctor will ask detailed questions about your daily activities [2].
In many cases, they will also recommend a supervised exercise test (such as a treadmill test in the clinic). This test helps reveal hidden symptoms, like shortness of breath or dizziness, that you might not notice normally [3][4]. In one screening registry, about 15% of people who seemed asymptomatic actually experienced symptoms or warning signs during a treadmill test [4]. Note: Never try to test your physical limits on your own to see if you have symptoms; exercise testing must always be supervised by medical professionals.
Strong Objective Triggers for Valve Replacement
Even if you are genuinely symptom-free, certain test results are strong, established signals that it is time for a valve replacement:
- Decreased Heart Pumping Function: The most critical measure is your Left Ventricular Ejection Fraction (LVEF), which calculates the percentage of blood your heart pumps out with each beat. Major cardiology guidelines strongly recommend valve replacement if your LVEF drops below 50% due to aortic stenosis [1][5].
- Symptoms Provoked by Testing: If a supervised exercise test triggers obvious symptoms like chest pain or shortness of breath, intervention is clearly recommended [6].
Risk Factors That May Prompt Early Intervention
Other test results do not automatically mandate a procedure but are significant risk markers. If these occur, your Heart Team will likely discuss whether you should consider early intervention rather than continued waiting:
- Borderline LVEF Declines: Some recent European guidelines suggest considering intervention if LVEF drops below 55%, while US guidelines might consider it if your LVEF shows a progressive decline to below 60% over repeated echocardiograms [7][8][9].
- Very Severe Valve Narrowing: If the peak aortic jet velocity (Vmax)—the speed of blood flowing through the narrowed valve—reaches 5.0 meters per second (m/s) or higher, it indicates very severe stenosis [10][11].
- Rapid Progression of Disease: If sequential echocardiograms show the Vmax is increasing rapidly (by 0.3 m/s or more per year) and your valve is severely calcified, early intervention may be advised [6][7].
- Abnormal Exercise Blood Pressure or Rhythm: During a stress test, if your systolic blood pressure drops below its starting baseline, or if you develop sustained irregular heartbeats (ventricular arrhythmias), it signals your heart is struggling to compensate [6][4].
- Elevated Biomarkers or Subclinical Damage: Blood tests can check for BNP or NT-proBNP, proteins released when the heart muscle is stressed. Markedly elevated or rapidly rising levels are associated with higher risks [12]. However, these numbers provide context rather than a standalone reason for surgery, as age, kidney disease, or atrial fibrillation can also raise them [13]. Advanced imaging might also reveal early heart muscle damage, such as reduced global longitudinal strain (GLS) or scarring (fibrosis) on an MRI [14][15].
The Shift Toward Earlier Treatment
Historically, the standard was to wait until symptoms developed or traditional triggers (like LVEF below 50%) were met. However, recent clinical trials and updated 2025 guidelines suggest that early intervention may benefit carefully selected patients [16].
For example, the EARLY TAVR trial studied older, low-surgical-risk patients with asymptomatic severe aortic stenosis and preserved LVEF. It found that early Transcatheter Aortic Valve Replacement (TAVR) reduced the combined risk of death, stroke, or unplanned cardiovascular hospitalization compared to clinical surveillance [17]. Similarly, trials like AVATAR have shown benefits for early Surgical Aortic Valve Replacement (SAVR) in selected low-risk patients [18].
Choosing early intervention requires balancing the benefits against procedural trade-offs. TAVR carries risks like a potential need for permanent pacemakers or valve leaks, while SAVR involves a longer surgical recovery. Both require planning for the lifetime durability of the artificial valve [19]. Treatment choice is highly individualized based on your age, valve anatomy, life expectancy, and need for other cardiac surgeries [20].
Active Surveillance and Your Safety Net
If you and your doctor choose active surveillance, “waiting” does not mean doing nothing. It requires a strict, structured plan:
- Routine Check-ups: You will need a clinical exam and echocardiogram every 6 to 12 months. If your disease is progressing rapidly or is very severe, your Heart Team may shorten this interval to 6 months or less [21].
- Early Warning Safety Net: Do not wait for your next appointment if things change. Call your cardiology team promptly if you notice a gradual decline in your stamina, new fatigue, or mild shortness of breath during activities.
- Urgent Action: Seek immediate emergency medical care if you experience fainting (syncope) or near-fainting, chest pain, or sudden and severe shortness of breath at rest.
Common questions in this guide
Can I safely wait if I have severe aortic stenosis but no symptoms?
What findings mean I need aortic valve replacement even without symptoms?
How do doctors know whether I am truly symptom-free?
How often will I need checkups if I choose watchful waiting?
When should I call my cardiologist or seek emergency care?
How are TAVR and SAVR chosen for asymptomatic severe aortic stenosis?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Exercise testing
Would a supervised exercise test help show whether I have any hidden symptoms?
Heart function tests
How would my heart's pumping function be measured, and what results would call for valve replacement?
Follow-up care
What checkups would I need over time, and how often would my echocardiogram be repeated?
Related questions
Show more
Get notified when new evidence is published on aortic valve stenosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (21)
- 1
Relationship Between Left Ventricular Ejection Fraction and Mortality in Asymptomatic and Minimally Symptomatic Patients With Severe Aortic Stenosis.
Bohbot Y, de Meester de Ravenstein C, Chadha G, et al.
JACC. Cardiovascular imaging 2019; (12(1)):38-48 doi:10.1016/j.jcmg.2018.07.029.
PMID: 30448114 - 2
Aortic Stenosis: Diagnosis and Treatment.
Grimard BH, Safford RE, Burns EL
American family physician 2016; (93(5)):371-8.
PMID: 26926974 - 3
Exercise testing in patients with asymptomatic moderate or severe aortic stenosis.
Saeed S, Rajani R, Seifert R, et al.
Heart (British Cardiac Society) 2018; (104(22)):1836-1842 doi:10.1136/heartjnl-2018-312939.
PMID: 29654094 - 4
Treadmill Stress Test in Patients With Asymptomatic Severe Aortic Stenosis: A Prespecified Registry-Based Follow-Up of the EARLY TAVR Randomized Clinical Trial.
Généreux P, Schwartz A, Lindman BR, et al.
JAMA cardiology 2026; (11(9)):802-809 doi:10.1001/jamacardio.2026.2527.
PMID: 42485012 - 5
Management of Asymptomatic Severe Aortic Stenosis: Current Evidence and Future Directions.
Laterra G, Agnello F, Strazzieri O, et al.
Journal of clinical medicine 2025; (14(21)) doi:10.3390/jcm14217549.
PMID: 41226944 - 6
Prognostic Value and Safety of Serial Exercise Echocardiography in Asymptomatic Severe Aortic Stenosis.
Abergel E, Venner C, Tribouilloy C, et al.
Journal of the American Heart Association 2025; (14(1)):e036599 doi:10.1161/JAHA.124.036599.
PMID: 39704221 - 7
Management of asymptomatic severe aortic stenosis: A critical review of guidelines and clinical outcomes.
Grbac AJ, Lee MGY, Chye D, et al.
American heart journal 2025; (288()):28-40 doi:10.1016/j.ahj.2025.04.012.
PMID: 40246047 - 8
Risk Stratification of Severe Aortic Stenosis With Preserved Left Ventricular Ejection Fraction Using Peak Aortic Jet Velocity: An Outcome Study.
Bohbot Y, Rusinaru D, Delpierre Q, et al.
Circulation. Cardiovascular imaging 2017; (10(10)) doi:10.1161/CIRCIMAGING.117.006760.
PMID: 29021260 - 9
ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.
Lee G, Chikwe J, Milojevic M, et al.
European heart journal 2023; (44(10)):796-812 doi:10.1093/eurheartj/ehac803.
PMID: 36632841 - 10
Aortic Stenosis: Changing Disease Concepts.
Rashedi N, Otto CM
Journal of cardiovascular ultrasound 2015; (23(2)):59-69 doi:10.4250/jcu.2015.23.2.59.
PMID: 26140146 - 11
Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics.
Lancellotti P, Magne J, Dulgheru R, et al.
JAMA cardiology 2018; (3(11)):1060-1068 doi:10.1001/jamacardio.2018.3152.
PMID: 30285058 - 12
B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.
Nakatsuma K, Taniguchi T, Morimoto T, et al.
Heart (British Cardiac Society) 2019; (105(5)):384-390 doi:10.1136/heartjnl-2018-313746.
PMID: 30530820 - 13
Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis.
Henri C, Dulgheru R, Magne J, et al.
The Canadian journal of cardiology 2016; (32(2)):183-9.
PMID: 26371385 - 14
Prognostic Importance of Left Ventricular Global Longitudinal Strain in Patients with Severe Aortic Stenosis and Preserved Ejection Fraction.
Thellier N, Altes A, Appert L, et al.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2020; (33(12)):1454-1464 doi:10.1016/j.echo.2020.07.002.
PMID: 32919856 - 15
Novel Biomarkers and Advanced Cardiac Imaging in Aortic Stenosis: Old and New.
Drăgan A, Mateescu AD
Biomolecules 2023; (13(11)) doi:10.3390/biom13111661.
PMID: 38002343 - 16
Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective.
Cook CM, Pibarot P, Tarantini G, et al.
Journal of the American College of Cardiology 2026; (87(4)):414-438 doi:10.1016/j.jacc.2025.10.074.
PMID: 41636408 - 17
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis.
Généreux P, Schwartz A, Oldemeyer JB, et al.
The New England journal of medicine 2025; (392(3)):217-227 doi:10.1056/NEJMoa2405880.
PMID: 39466903 - 18
Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial.
Banovic M, Putnik S, Penicka M, et al.
Circulation 2022; (145(9)):648-658 doi:10.1161/CIRCULATIONAHA.121.057639.
PMID: 34779220 - 19
TAVR vs. SAVR for severe aortic stenosis in the low and intermediate surgical risk population: An updated meta-analysis, meta-regression, and trial sequential analysis.
Krishna MM, Joseph M, Ezenna C, et al.
Cardiovascular revascularization medicine : including molecular interventions 2025; (79()):78-89 doi:10.1016/j.carrev.2025.05.021.
PMID: 40425422 - 20
International Age and Use Criteria for Transcatheter and Surgical Aortic Valve Replacement.
Sharma R, Srivats S, Ata F, Shuhaiber J
Reviews in cardiovascular medicine 2026; (27(6)):49368 doi:10.31083/RCM49368.
PMID: 42416597 - 21
Calcific Aortic Stenosis: A Review.
Otto CM, Newby DE, Hillis GS
JAMA 2024; (332(23)):2014-2026 doi:10.1001/jama.2024.16477.
PMID: 39527048
This page is for informational purposes only and does not constitute medical advice. Your cardiology Heart Team should interpret your test results and advise whether surveillance, TAVR, or SAVR is appropriate for you.